Telesis Bio gains on 2022 sales forecast raise

Telesis Bio

09/11/2022 11:55

** Telesis Bio Inc's shares  DNAY.O  rise 6.6% to $1.80
premarket
    ** Healthcare service provider raises 2022 sales forecast to
between $23 million and $25 million from $22 million to $24
million previously  urn:newsml:reuters.com:*:nGNX3v8N96
    ** Co's revenue in Q3 more than doubled to $6.7 million
compared with $2.8 million for the same period in 2021
    ** Up to Tuesday's close, stock down ~85% YTD 
 (Reporting by Khushi Mandowara)
 ((Khushi.Mandowara@thomsonreuters.com;))